IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AMANDA L LOVOLD

Allopathic & Osteopathic Physicians Family Medicine

NPI
1821252800
CMS profile
310133
Location
ST CLOUD, MN

General Payments · PY2018–2024

$363,997.57

  • Reported across 187 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$70,655.37

42 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family Medicine MN All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $70,635.00 41
Food and Beverage $20.37 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $70,635.00 41
Novo Nordisk AS $20.37 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $46,320.00 19
PY2019 $47,320.00 24
PY2020 $48,720.00 24
PY2021 $46,660.00 23
PY2022 $63,361.50 34
PY2023 $40,960.70 21
PY2024 $70,655.37 42

Payment records · PY2024 (42)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Novo Nordisk Inc $20.37 10/23/2024 Food and Beverage Undisputed 01/23/2026 1108574108 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137624145 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137624148 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137624152 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137624156 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137624159 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137624163 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 04/08/2024 Consulting Fee Undisputed 01/23/2026 1137624167 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137624170 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137624174 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137624178 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137624182 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 05/15/2024 Consulting Fee Undisputed 01/23/2026 1137624185 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 05/20/2024 Consulting Fee Undisputed 01/23/2026 1137624189 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 05/24/2024 Consulting Fee Undisputed 01/23/2026 1137624193 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137624196 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137624200 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 07/10/2024 Consulting Fee Undisputed 01/23/2026 1137624204 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137624207 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137624211 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137624215 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137624219 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137624223 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137624226 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137624230 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 08/21/2024 Consulting Fee Undisputed 01/23/2026 1137624233 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137624237 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137624241 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 10/02/2024 Consulting Fee Undisputed 01/23/2026 1137624244 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,115.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137624248 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137624252 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137624256 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137624259 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137624263 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1137624266 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 12/04/2024 Consulting Fee Undisputed 01/23/2026 1137624270 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 12/04/2024 Consulting Fee Undisputed 01/23/2026 1137624274 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137624278 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,230.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137624281 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137624285 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137624289 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 12/16/2024 Consulting Fee Undisputed 01/23/2026 1137624293 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.